BioCentury
ARTICLE | Financial News

argenx, G1 price follow-ons, CRISPR proposes

September 19, 2018 5:34 PM UTC

argenx S.E. (Euronext:ARGX; NASDAQ:ARGX) and G1 Therapeutics Inc. (NASDAQ:GTHX) raised $300.6 million and $180 million, respectively, in follow-ons that priced after hours Tuesday.

argenx sold 3.5 million ADSs at $86.50, an 8% discount to its NASDAQ close of $93.77 on Monday, when it proposed after hours to raise $300 million. Morgan Stanley, Cowen, Evercore ISI, Kempen and Nomura are underwriters. argenx fell 7% on NASDAQ Tuesday, and dipped another $7.32 to $79.98 on Wednesday. Its Euronext shares lost €9.60 (12%) to €71.80 on Wednesday...